Analyst on Novo stock: The risk of disappointments is bigger than the chance of surprises
2021 has been a golden year for Novo Nordisk, says a Jyske Bank analyst, whose recommendation for Novo stock is "hold" because of noteworthy price increases.
by marketwire, translated by daniel pedersen
Danish bank Jyske Bank is raising its share price target for Novo Nordisk stock to DKK 780 (USD 117.6) from DKK 670 (USD 100.1), according to an analysis the bank has conducted.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Novo Nordisk acquires Dicerna for USD 3.3bn
For subscribers
